Reuters logo
3 个月前
BRIEF-X-Chem and Vertex enter into multi-target genetic disease collaboration
2017年5月16日 / 下午12点39分 / 3 个月前

BRIEF-X-Chem and Vertex enter into multi-target genetic disease collaboration

May 16 (Reuters) - Vertex Pharmaceuticals Inc

* X-Chem and Vertex enter into multi-target genetic disease collaboration

* X-Chem - Vertex will have the option to license lead-like hits discovered under the collaboration

* X-Chem - Vertex will be responsible for further development and commercialization of the resulting programs

* X-Chem - will receive an upfront payment and potential research, development and regulatory milestones and licensing fees Source text for Eikon: (bit.ly/2qrFISY) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below